Search
Memorial Sloan Kettering Cancer Center (MSK) today announced that Kenneth Offit, MD, MPH, and Ross L. Levine, MD, have been elected as Fellows of the AACR Academy, one of the highest honors bestowed by the American Association for Cancer Research (AACR).
A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
Lisa M. DeAngelis, MD and Elizabeth Schille, RN, OCN were recognized for their work in the the field of neuro-oncology.
The President and CEO and Chair of the Board at Memorial Sloan Kettering Cancer Center introduce the year's highlights in their introductory letter to the 2023 Annual Report.
The Organ Preservation in Patients with Rectal Adenocarcinoma (OPRA) trial demonstrated that the watch-and-wait strategy is safe for patients with stage 2 and stage 3 rectal cancers that achieve a clinical complete response (CCR) or near-complete clinical response (NCR) to total neoadjuvant therapy (TNT).
MSK researchers have identified a compound that kills glioblastoma cells using a mechanism that’s completely different from earlier treatments.
Every year, GSK awards fellowships to two third-year students and six second-year students based on academic excellence.
Elaine Mosqueda has traveled far in so many ways since moving from the Philippines to the United States at the age of 21.
We are thrilled to welcome 20 undergraduates to our ten-week course mentored by GSK’s outstanding faculty.
The MSK Clinical Research Roundup keeps physicians up to date on the latest and most noteworthy patient treatments, clinical trials, and translational research happening at MSK.